rustavo 20 mg filmsko obložene tablete
teva b.v. - rosuvastatin - filmsko obložena tableta - rosuvastatin 20 mg / 1 tableta - rosuvastatin
rustavo 40 mg filmsko obložene tablete
teva b.v. - rosuvastatin - filmsko obložena tableta - rosuvastatin 40 mg / 1 tableta - rosuvastatin
rustavo 5 mg filmsko obložene tablete
teva b.v. - rosuvastatin - filmsko obložena tableta - rosuvastatin 5 mg / 1 tableta - rosuvastatin
vosustat 5 mg filmsko obložene tablete
pharmaswiss Česká republika s.r.o. - rosuvastatin - filmsko obložena tableta - rosuvastatin 5 mg / 1 tableta - rosuvastatin
enzepi
allergan pharmaceuticals international ltd - prašek trebušne slinavke - eksocrine pankreasne pomanjkljivosti - digestivi, vklj. encimi - zdravljenje s pankreatičnimi encimi pri eksokrinalni insuficienci pankreasa zaradi cistične fibroze ali drugih stanj (e. kronični pankreatitis, post pancreatectomy ali rak trebušne slinavke). enzepi je navedeno v dojenčki, otroci, mladostniki in odrasli.
clynav
elanco gmbh - puk-spdv-poly2#1 dna plazmida kodiranje za lososa trebušne slinavke bolezni virus beljakovin - immunologicals za atlantski losos, - atlantski losos - za aktivno imunizacijo atlantskega lososa za zmanjšanje oslabljena dnevne telesne mase in zmanjšanje umrljivosti in srca, trebušne slinavke in skeletne mišice poškodb, ki jih povzročajo trebušni slinavki, bolezni po okužbi z salmonidne alphavirus podtipa 3 (sav3).
dutrebis
merck sharp dohme limited - lamivudine, raltegravir kalij - okužbe z virusom hiv - antivirals for systemic use, antivirals for treatment of hiv infections, combinations - dutrebis je naveden v kombinaciji z drugimi anti‑retroviral zdravili za zdravljenje okužbe z virusom človeške imunske pomanjkljivosti (hiv‑1) pri odraslih, mladostnikih in otroci v starosti od 6 let in tehtanje vsaj 30 kg brez sedanjosti ali preteklosti dokaz virusne odpornostjo na protivirusna zdravila institucij (sklop prenos integraze) in nrti (nukleozidni zaviralec reverzne transkriptaze) razredov (glej točki 4. 2, 4. 4 in 5.
tysabri
biogen netherlands b.v. - natalizumab - multiple skleroza - selektivni imunosupresivi - tysabri is indicated as single disease modifying therapy in adults with highly active relapsing remitting multiple sclerosis for the following patient groups: , patients with highly active disease activity despite a full and adequate course of treatment with at least one disease modifying therapy (dmt) (for exceptions and information about washout periods see sections 4. 4 in 5. 1), , or, patients with rapidly evolving severe relapsing remitting multiple sclerosis defined by 2 or more disabling relapses in one year, and with 1 or more gadolinium enhancing lesions on brain mri or a significant increase in t2 lesion load as compared to a previous recent mri.
tyruko
sandoz gmbh - natalizumab - multiple sclerosis, relapsing-remitting; multiple sclerosis - imunosupresivi - tyruko is indicated as single disease modifying therapy in adults with highly active relapsing remitting multiple sclerosis (rrms) for the following patient groups: patients with highly active disease despite a full and adequate course of treatment with at least one disease modifying therapy (dmt) (for exceptions and information about washout periods see sections 4. 4 in 5. 1), or, patients with rapidly evolving severe rrms defined by 2 or more disabling relapses in one year, and with 1 or more gadolinium enhancing lesions on brain magnetic resonance imaging (mri) or a significant increase in t2 lesion load as compared to a previous recent mri.
atriance
sandoz pharmaceuticals d.d. - nelarabin - predkroglomerna limfoma t-celična limfoblastna levkemija - antineoplastična sredstva - nelarabine je indiciran za zdravljenje bolnikov z t-celic acute lymphoblastic levkemijo (t-all) in t-celic lymphoblastic limfom (t-lbl), katerih bolezen ni odgovorila, ali je relapsed po zdravljenju z vsaj dvema kemoterapijo regimens. due to the small patient populations in these disease settings, the information to support these indications is based on limited data.